Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126489552 | 12648955 | 2 | F | 20160728 | 20160921 | 20160812 | 20160922 | PER | US-CELGENEUS-USA-2016082999 | CELGENE | 73.51 | YR | F | Y | 86.71000 | KG | 20160922 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126489552 | 12648955 | 1 | PS | THALOMID | THALIDOMIDE | 1 | Oral | 50 MILLIGRAM | D | U | B0028AJ | 20785 | 50 | MG | CAPSULES | ||||
126489552 | 12648955 | 2 | SS | THALOMID | THALIDOMIDE | 1 | D | U | B0028AJ | 20785 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126489552 | 12648955 | 1 | Plasma cell myeloma |
126489552 | 12648955 | 2 | 5q minus syndrome |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126489552 | 12648955 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126489552 | 12648955 | Death | |
126489552 | 12648955 | Infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126489552 | 12648955 | 1 | 20151029 | 0 |